



















Generic medicines are recommended to be used in Japan recently, therefore, phar-
macists have to evaluate their quality in altering from brand to generic drugs. In those 
cases, evaluation should be based on both pharmaceuticals and information.  Equivalence 
of bioavailability is guaranteed in approval by Ministry of Health, Labour and Welfare, 
however, pharmaceutical evaluation is not fully compared.  Objective evaluation of the 
information is not systematically done.  Therefore, this study evaluated the 16 brand and 
generic tablets of nitrendipine that are commercially available in Japan.  In the compari-
son of pharmaceutical additives, each brand or generic has unique combination of variety 
of additives. This study also compared the pharmacokinetic parameters indicated in the 
package insert.  Although the conditions of the clinical examinations were very similar, 
the difference of the values of Cmax or AUC was more than double.  These results indi-
cate the difficulty in comparing these values among different generic tablets.  This study 
also evaluated the information in terms of its contents, availability and accessibility.  The 
contents were evaluated according to criteria for evaluation of drug information 3rd edi-
tion, and the availability and accessibility were graded according to new criteria.  The 
points of contents, availability and accessibility were 27.4-90.8 (full mark: 100), 11-42 (full 
mark: 42) and 0-18 (full mark: 18), respectively, resulting in the total of 38.4 to 147.8 (full 
mark: 160), indicating a wide range in the quality in information.
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合計最高点：24 各種お知らせ 3 0



















　　添加物　　　　　　　　　　　製剤番号 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
ステアリン酸マグネシウム ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○
○○○○○スーロルセ
○○○○○○○クルタ





































が最も多く 26 件であった。後発品では 24 件の






















● ● ● ●
























































1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
○○○○○緯経の発開.1要概.1 ○ ○ ○ ○ ○ ○
2. 製品の特徴及び有用性 ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○
3. 主な外国での発売状況 ○ ○ ○
2. 有効成分 1. 記述 ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○
○○○性湿吸.2
○○○○○○○○○性定安.3
3. 製品の性質 1. 記述 ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○
2. 添加物 ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○
3. 安定性 ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○
4. 配合変化
○○験試出溶.5 ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○
4. 臨床データ 1. 用法・用量 ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○





5. 薬理 1. 作用部位・作用機序 ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○
○○○○績成験試るけ付裏を効薬.2




②胎児への移行性 ○ ○ ○ ○ ○

















発品は 39 点（42 点満点のうちの後発品情報は










験の 3項目を調査した。後発品 15 品目中、全
ての情報が得られた製品は 13 品目、2種類が 1
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50.4 ～ 82.8 ポイントに対して後発品では平均
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